13 February 2017Americas

Second Circuit revives competition suit against Takeda

The US Court of Appeals for the Second Circuit has partly revived a competition case against Takeda that accuses the company of delaying generic versions of its diabetes drug Actos (pioglitazone).

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk